# Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty

> **NCT01977339** · PHASE4 · WITHDRAWN · sponsor: **St. Luke's-Roosevelt Hospital Center**

## Conditions studied

- Total Knee Arthroplasty

## Interventions

- **DRUG:** Liposome Bupivacaine
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT01977339
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** New departmental administration, loss of key study faculty
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01977339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01977339, "Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01977339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*